There is rich cross-talk between miRNAs and TGFβ signaling comprising of feedback regulation.18,19 As a result, miRNAs have emerged as promising candidates for anti-cancer therapeutics blocking TGFβ signaling. The gene discussed is TGFB1; the disease is cancer.